Masimo Corp
NASDAQ:MASI

Watchlist Manager
Masimo Corp Logo
Masimo Corp
NASDAQ:MASI
Watchlist
Price: 172.96 USD 2.27% Market Closed
Market Cap: 9.3B USD
Have any thoughts about
Masimo Corp?
Write Note

Masimo Corp
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Masimo Corp
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Masimo Corp
NASDAQ:MASI
Other Current Liabilities
$113.9m
CAGR 3-Years
26%
CAGR 5-Years
25%
CAGR 10-Years
17%
Becton Dickinson and Co
NYSE:BDX
Other Current Liabilities
$6.8B
CAGR 3-Years
238%
CAGR 5-Years
117%
CAGR 10-Years
67%
Boston Scientific Corp
NYSE:BSX
Other Current Liabilities
$1B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Other Current Liabilities
$699m
CAGR 3-Years
5%
CAGR 5-Years
19%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Other Current Liabilities
$1.6B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
-3%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Current Liabilities
$590.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
10%
No Stocks Found

Masimo Corp
Glance View

Market Cap
9.3B USD
Industry
Health Care

Masimo Corp. is a pioneering medical technology company that specializes in innovative non-invasive monitoring solutions. Founded in 1989 and headquartered in Irvine, California, Masimo revolutionized the field of patient monitoring with its groundbreaking pulse oximetry technology, which provides accurate blood oxygen saturation levels in a wide range of settings, from hospitals to home care. The company has continued to expand its product portfolio, introducing advanced monitoring solutions that measure multiple physiological parameters critical for patient care. With a strong emphasis on research and development, Masimo maintains a competitive edge, driving both innovation and customer loyalty across the global healthcare market. For investors, Masimo presents a compelling growth story. As the demand for effective remote patient monitoring rises, driven by trends in telehealth and an aging population, the company is well-positioned to capitalize on these opportunities. Masimo's focus on integrating sophisticated technologies, such as measure-through motion and low perfusion capabilities, sets it apart from traditional monitoring devices. Moreover, with a solid financial foundation and a history of steady revenue growth, Masimo continues to demonstrate resilience in the face of market challenges. This combination of innovation, market demand, and financial stability makes Masimo Corp. an intriguing option for investors looking to tap into the evolving landscape of healthcare technology.

MASI Intrinsic Value
128.09 USD
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Masimo Corp's Other Current Liabilities?
Other Current Liabilities
113.9m USD

Based on the financial report for Sep 28, 2024, Masimo Corp's Other Current Liabilities amounts to 113.9m USD.

What is Masimo Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
17%

Over the last year, the Other Current Liabilities growth was 4%. The average annual Other Current Liabilities growth rates for Masimo Corp have been 26% over the past three years , 25% over the past five years , and 17% over the past ten years .

Back to Top